Giovanni Abbadessa

Company: Sanofi

Job title: Vice President, Head of Oncology Early Development

Seminars:

Live Presenter Q&A 4:25 pm

Ask the speakers your most burning questions!Read more

day: Day Two

THOR-707, a Novel Non Alpha IL-2, in Patients with Advanced/ Metastatic Solid Tumors 4:05 pm

Hypothesis: why non alpha • Features: how THOR-707 spares the alpha receptor while binding to the beta-gamma receptor • Data: preliminary results from the ongoing Phase 1-2 clinical trial in patients with solid tumorsRead more

day: Day Two